Physician profile
Michael Sabia
NPI 1780881029
$13,369.27
in general payments reported to CMS, 2019-2025
15 companies · $1,748 in 2025
The $1,748 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,635 · 2020: $242 · 2021: $856 · 2022: $597 · 2023: $645 · 2024: $646 · 2025: $1,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,039.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $7,796.15 | 2019 | |
| Medtronic, INC. | $1,341.32 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Boston Scientific Corporation | $1,113.80 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept Rf Probe, General - Pain Management |
| Abbott Laboratories | $819.74 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $625.79 | 2019-2022 | |
| Saluda Medical Americas, INC. | $479.39 | 2024-2025 | Evoke |
| Globus Medical, INC. | $269.41 | 2025 | Senza |
| Biotronik Nro, INC. | $143.48 | 2025 | Prospera |
| Vertiflex, INC. | $133.73 | 2019 | |
| Averitas Pharma INC. | $124.99 | 2023 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $124.98 | 2023 | Iovera |
| Stryker Corporation | $121.91 | 2025 | Mild Device Kit |
| Medtronic USA, INC. | $120.12 | 2020 | |
| Si-Bone, INC. | $109.09 | 2021 | |
| Stimwave Technologies Incorporated | $45.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sabia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.